scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1365-2125.1991.TB05587.X |
P8608 | Fatcat ID | release_hiw7q46ajveytoypjldiw5qove |
P932 | PMC publication ID | 1368574 |
P698 | PubMed publication ID | 1867959 |
P5875 | ResearchGate publication ID | 21287944 |
P2093 | author name string | Page MA | |
Shenfield GM | |||
Boutagy JS | |||
P2860 | cites work | Characterization of the common genetic defect in humans deficient in debrisoquine metabolism | Q34049056 |
Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae | Q35877286 | ||
The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci | Q38618586 | ||
Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily | Q41750193 | ||
Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers | Q41904363 | ||
Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices | Q42250442 | ||
Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations | Q44696228 | ||
Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus | Q51665590 | ||
Pharmacogenetics of tolbutamide metabolism in humans | Q67017361 | ||
Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide | Q68411894 | ||
Lack of relationship between tolbutamide metabolism and debrisoquine oxidation phenotype | Q68687397 | ||
Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition | Q69066656 | ||
Drug absorption, metabolism, and excretion. IX. Some new aspects of pharmacokinetics on tolbutamide in rabbits | Q69615550 | ||
Normal metabolism of debrisoquine and theophylline in a slow tolbutamide metaboliser | Q69848110 | ||
The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination | Q70426611 | ||
Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man | Q70644714 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 649-654 | |
P577 | publication date | 1991-06-01 | |
P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
P1476 | title | A screening test for slow metabolisers of tolbutamide | |
P478 | volume | 31 |